GlassScriptPhysician profile
Ameena Anees
NPI 1588644488
$1,939.13
in general payments reported to CMS, 2019-2025
17 companies · $273 in 2025
The $273 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,089 · 2021: $46.24 · 2022: $13.49 · 2023: $68.65 · 2024: $450 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $707 · Education: $84.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $706.84 |
| Education | $84.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $402.16 | 2019-2025 | Linzess, Viberzi, Creon |
| Pfizer INC. | $267.54 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $249.42 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $215.06 | 2019 | |
| Janssen Biotech, INC. | $178.78 | 2019-2025 | Tremfya, Stelara |
| Phathom Pharmaceuticals, INC. | $157.04 | 2024 | Voquezna |
| Qol Medical, LLC | $128.55 | 2019-2024 | Sucraid |
| Ardelyx, INC. | $119.02 | 2024 | Ibsrela |
| Braintree Laboratories, INC. | $42.04 | 2019 | |
| Gilead Sciences, INC. | $37.44 | 2019-2024 | |
| Concordia Pharmaceuticals INC. | $30.90 | 2019 | |
| Mauna Kea Technologies, INC. | $28.02 | 2019-2025 | |
| Genzyme Corporation | $20.28 | 2025 | |
| Intercept Pharmaceuticals, INC. | $18.36 | 2019 | |
| Celgene Corporation | $18.26 | 2024 | Zeposia |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $14.72 | 2019 | |
| Ironwood Pharmaceuticals, INC | $11.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ameena Anees listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.